Down-regulation of CD20 on B cells upon CD40 activation

被引:47
作者
Anolik, J
Looney, RJ
Bottaro, A
Sanz, I
Young, F
机构
[1] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Immunol & Microbiol, Rochester, NY 14642 USA
关键词
CD20; CD40; B lymphocyte;
D O I
10.1002/eji.200323515
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD20 is a B cell-specific surface antigen that is thought to play an important role in B cell activation and proliferation, possibly by functioning as a calcium channel or interacting with other cell surface molecules important in B cell signal transduction, such as CD40. In this study, it was found that stimulation through CD40 caused a dramatic decrease in the expression of surface CD20 in normal human B lymphocytes. Down-regulation of CD20 was time and ligand concentration dependent, beginning as early as 15 min after incubation with CD40 ligand-transfected fibroblasts. The rapid onset of this effect in the presence of stable steady-state mRNA levels suggests that CD20 down-regulation occurs at a nontranscriptional level. Confocal fluorescent microscopy indicates that CD20 and CD40 are internalized upon CD40 activation. Specifically, CD20 translocates into lipid rafts and is internalized into cytoplasmic vesicles, in a process that is inhibited by cytochalasin B and protein kinase C antagonists. Paradoxically, one functional consequence of CD20 down-regulation was enhanced calcium signaling upon CD20 cross-linking. These observations support the notion that CD20 engages downstream signaling pathways that alter calcium homeostasis rather than functioning as a calcium channel itself, such signal transduction is enhanced upon CD20 internalization, and CD40 is a regulator of CD20-mediated signaling.
引用
收藏
页码:2398 / 2409
页数:12
相关论文
共 37 条
[1]  
Anolik IH, 2001, ARTHRITIS RHEUM, V44, pS387
[2]   The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus [J].
Anolik, JH ;
Campbell, D ;
Felgar, RE ;
Young, F ;
Sanz, I ;
Rosenblatt, J ;
Looney, RJ .
ARTHRITIS AND RHEUMATISM, 2003, 48 (02) :455-459
[3]   ADRIAMYCIN(HYDRAZONE)-ANTIBODY CONJUGATES REQUIRE INTERNALIZATION AND INTRACELLULAR ACID-HYDROLYSIS FOR ANTITUMOR-ACTIVITY [J].
BRASLAWSKY, GR ;
KADOW, K ;
KNIPE, J ;
MCGOFF, K ;
EDSON, M ;
KANEKO, T ;
GREENFIELD, RS .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (06) :367-374
[4]   ROLE OF THE BP35 CELL-SURFACE POLYPEPTIDE IN HUMAN B-CELL ACTIVATION [J].
CLARK, EA ;
SHU, G ;
LEDBETTER, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (06) :1766-1770
[5]   Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment [J].
Davis, TA ;
Grillo-López, AJ ;
White, CA ;
McLaughlin, P ;
Czuczman, MS ;
Link, BK ;
Maloney, DG ;
Weaver, RL ;
Rosenberg, J ;
Levy, R .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3135-3143
[6]  
DEANS JP, 1993, J IMMUNOL, V151, P4494
[7]   Rapid redistribution of CD20 to a low density detergent-insoluble membrane compartment [J].
Deans, JP ;
Robbins, SM ;
Polyak, MJ ;
Savage, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :344-348
[8]   TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes:: Role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase [J].
Dri, P ;
Gasparini, C ;
Menegazzi, R ;
Cramer, R ;
Albéri, L ;
Presani, G ;
Garbisa, S ;
Patriarca, P .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :2165-2172
[9]   Compartmentalized activation of the high affinity immunoglobulin E receptor within membrane domains [J].
Field, KA ;
Holowka, D ;
Baird, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (07) :4276-4280
[10]  
GOLAY JT, 1985, J IMMUNOL, V135, P3795